Claims for Patent: 8,013,214

Summary for Patent: 8,013,214

Title:	Maize having an improved digestibility
Abstract:	The invention relates to a maize plant having a decrease in the CCR enzyme activity due to the presence of the 3318 allele and its use for ensilage.
Inventor(s):	Murigneux; Alain (La Roche Blanche, FR), Martinant; Jean-Pierre (Vertaizon, FR), Tatout; Christophe (Feurs, FR)
Assignee:	BIOGEMMA S.A.S. (Paris, FR)
Application Number:	11/664,171
Patent Claims:	1. A method for obtaining a maize exhibiting increased digestibility, comprising the step of introgressing the .DELTA. 3318 allele into said maize. 2. The method according to claim 1, comprising the steps: a) crossing a first maize line that has the .DELTA. 3318 allele with a second maize that does not have said allele, b) genotyping the progeny obtained and selecting the descendants having the .DELTA. 3318 allele that have the best genome ratio as regards said second maize, c) performing a back cross of said descendants with said elite second maize line that can be used for the production of hybrids, d) repeating, if necessary, steps b) and c) until an isogenic line of said second maize, having the .DELTA. 3318 allele, is obtained, e) optionally, performing a self-pollination in order to obtain a plant that is homozygous for the .DELTA. 3318 allele. 3. A maize plant having the .DELTA. 3318 allele of the CCR1 gene, wherein said .DELTA. 3318 allele of the CCR1 gene comprises an insertion of a transposon in the first intron of the CCR1 gene, said insertion being located at position 632 of reference sequence SEQ ID NO: 1 representing an allele of the CCR1 gene, said .DELTA. 3318 allele being present in a representative sample of seeds deposited with NCIMB under the number NCIMB 41236. 4. A method for preparing a composition intended for livestock feed comprising the step of preparing silage with the maize according to claim 3. 5. A maize seed having the .DELTA. 3318 allele of the CCR1 gene, wherein said .DELTA. 3318 allele of the CCR1 gene comprises an insertion of a transposon in the first intron of the CCR1 gene, said insertion being located at position 632 of reference sequence SEQ ID NO: 1 representing an allele of the CCR1 gene, said .DELTA. 3318 allele being present in a representative sample of seeds deposited with NCIMB under the number NCIMB 41236.

Details for Patent 8,013,214

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2024-09-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2024-09-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2024-09-29